Chemotherapy‐induced peripheral neurotoxicity: A multifaceted, still unsolved issue
Guido Cavaletti(Bellvitge University Hospital), Stefano Tamburin(University of Verona), Paola Alberti(University of Milano-Bicocca), Andreas A. Argyriou(Agios Andreas Hospital), Nathan P. Staff(Mayo Clinic), Maryam B. Lustberg(Yale Cancer Center)
Cited by 98
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Guillain-Barré syndrome related to COVID-19 infection
|Neurology Neuroimmunology & Neuroinflammation|2020|340